Loading
Only a handful of insider records exist for XPhyto Therapeutics Corp. (formerly, CannaBunker Development Corp.), the last one from 11 July 2019, too few to describe a trend. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
XPhyto Therapeutics Corp. is a biotechnology company focused on developing innovative therapeutic solutions, particularly in the fields of infectious diseases and neurological disorders. Formerly known as CannaBunker Development Corp., it is listed on the XTSE.